These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35972839)

  • 61. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives.
    Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T
    Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743
    [TBL] [Abstract][Full Text] [Related]  

  • 62.
    Nguyen HD; Kim MS
    J Biomol Struct Dyn; 2024 Sep; 42(14):7128-7149. PubMed ID: 37477246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mannich-Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study.
    Alpan AS; Sarıkaya G; Çoban G; Parlar S; Armagan G; Alptüzün V
    Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 28379621
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
    Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3H)-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors.
    Uysal S; Parlar S; Tarikogullari AH; Aydin Kose F; Alptuzun V; Soyer Z
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700273. PubMed ID: 29527733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol-based new thiosemicarbazide and 1,3,4-thiadiazole derivatives.
    Alagöz T; Çalişkan FG; Bilgiçli HG; Zengin M; Sadeghi M; Taslimi P; Gulçin İ
    Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300370. PubMed ID: 37743251
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
    Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
    Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies.
    Mirzazadeh R; Asgari MS; Barzegari E; Pedrood K; Mohammadi-Khanaposhtani M; Sherafati M; Larijani B; Rastegar H; Rahmani H; Mahdavi M; Taslimi P; Üç EM; Gulçin İ
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2000471. PubMed ID: 33999440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis, characterization and biological screening of N-substituted derivatives of 5-benzyl-1,3,4-oxadiazole-2yl-2"-sulfanyl acetamide.
    Siddiqui SZ; Rehman A; Abbasi MA; Abbas N; Khan KM; Ashraf M; Ejaz SA
    Pak J Pharm Sci; 2013 May; 26(3):455-63. PubMed ID: 23625417
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biological evaluation and docking studies of some benzoxazole derivatives as inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Temiz-Arpaci O; Arisoy M; Sac D; Doganc F; Tasci M; Senol FS; Orhan IE
    Z Naturforsch C J Biosci; 2016 Nov; 71(11-12):409-413. PubMed ID: 27505087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
    Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors.
    Hameed S; Khan KM; Taslimi P; Salar U; Taskin-Tok T; Kisa D; Saleem F; Solangi M; Ahmed MHU; Rani K
    Int J Biol Macromol; 2022 Jun; 211():653-668. PubMed ID: 35568155
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
    Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
    Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chalcones bearing nitrogen-containing heterocyclics as multi-targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies.
    Sıcak Y; Kekeçmuhammed H; Karaküçük-İyidoğan A; Taşkın-Tok T; Oruç-Emre EE; Öztürk M
    J Mol Recognit; 2023 Jul; 36(7):e3020. PubMed ID: 37092742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New benzamide derivatives and their nicotinamide/cinnamamide analogs as cholinesterase inhibitors.
    Koca M; Bilginer S
    Mol Divers; 2022 Apr; 26(2):1201-1212. PubMed ID: 34165688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.